Takeda Pharmaceutical Co. Ltd. Licenses Recombineering Technology From Gene Bridges GmbH
HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Takeda Pharmaceutical Company Limited of Osaka, Japan has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges.